Ermelinda De Maio

Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE Trial

Emanuela Rossi, Alessandro Morabito, Francesca Di Rella et al. · Journal of Clinical Oncology · 2009 · 80 citations

Medicine, Endocrinology, Oncology +17

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Francesco Perrone, Michelino De Laurentiis, Sabino De Placido et al. · European Journal of Cancer · 2019 · 70 citations

Medicine, Gynecology, Oncology +17

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial

Francesco Perrone, Francesco Nuzzo, Francesca Di Rella et al. · Annals of Oncology · 2014 · 68 citations · Full text

Medicine, Geriatric Medicine, Oncology +12

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast

A. De Matteis, Francesco Nuzzo, Giuseppe D’Aiuto et al. · Cancer · 2002 · 56 citations · Full text

Medicine, Oncology, Pharmacology +15

Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly

Sandro Pignata, Ciro Gallo, Bruno Daniele et al. · Critical Reviews in Oncology/Hematology · 2006 · 52 citations

Medicine, Geriatric Medicine, Oncology +12